Effect of Vitamin D Administration on Glycemic Control in Patients with Type II Diabetes Mellitus and Vitamin D Deficiency
Men's Health Journal,
Vol. 5 No. 1 (2021),
6 Dey 2021
,
Page e29
https://doi.org/10.22037/mhj.v5i1.35210
Abstract
Introduction: The prevalence of diabetes mellitus (DM) and its morbidity and mortality are prominent all over the world. Observational data suggest that vitamin D deficiency is associated with insulin resistance. In this study, we aimed to assess this association. Methods: This study was a clinical trial consisting of 42 patients with type 2 DM who had vitamin D deficiency. The patients underwent vitamin D replacement with vitamin D pearls (50,000 iu) weekly for 10 weeks. The level of low-density lipoprotein (LDL), high-density lipoprotein (HDL), cholesterol (Chol), triglycerides (TG), hemoglobin A1c (HbA1C), 2 hour post prandial (2HPP), fasting blood sugar (FBS), body mass index (BMI), blood pressure (BP), and 25oHVitD3 were measured before and after the treatment in all patients. Data were analyzed with paired t test. Results: 100% of patients reached acceptable vitamin D level (above 30 mg/dl). No toxicity was reported. Changes in FBS, 2Hpp, HbA1C, Chol, SBP were significant and there was no significant change in LDL, HDL, and DBP. Conclusion: Screening for vitamin D deficiency and its replacement may have a beneficial effect on type 2 DM management and its associated risk factors. More studies with larger sample size and use of placebo are recommended.
- Diabetes mellitus type 2
- Vitamin D deficiency
- Lipid profile
- Blood pressure
How to Cite
References
Federation ID. IDF diabetes atlas ninth. Dunia: IDF. 2019.
Grumbach M, DM S. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Puberty: ontogeny, neuroendocrinology, physiology, and disorders Williams Textbook of Endocrinology. 2003;10:1115-286.
Association AD. 6. Glycemic targets: standards of medical care in diabetes—2018. Diabetes care. 2018;41(Supplement 1):S55-S64.
Lucas JA, Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, et al. Determinants of vitamin D status in older women living in a subtropical climate. Osteoporosis International. 2005;16(12):1641-8.
Kumar S, Davies M, Zakaria Y, Mawer E, Gordon C, Olukoga A, et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgraduate medical journal. 1994;70(824):440-3.
Heshmat R, Mohammad K, Majdzadeh S, Forouzanfar M, Bahrami A, Ranjbar Omrani G, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health. 2008;37(1):72-8.
Bouillon R. Non-classical actions of the vitamin D endocrine system. Bone. 2007;6(40):S9.
Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes care. 2012;35(3):565-73.
Kajbaf F, Mentaverri R, Diouf M, Fournier A, Kamel S, Lalau J-D. The association between 25-hydroxyvitamin D and hemoglobin A1c levels in patients with type 2 diabetes and stage 1–5 chronic kidney disease. International journal of endocrinology. 2014;2014.
Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, et al. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia. Diabetes, metabolic syndrome and obesity: targets and therapy. 2019;12:853.
Mezza T, Muscogiuri G, Sorice G, Prioletta A, Salomone E, Pontecorvi A, et al. Vitamin D deficiency: a new risk factor for type 2 diabetes. Annals of Nutrition and Metabolism. 2012;61(4):337-48.
Nazarian S, Peter JVS, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Translational research. 2011;158(5):276-81.
Sesti G. Pathophysiology of insulin resistance. Best practice & research Clinical endocrinology & metabolism. 2006;20(4):665-79.
Chertow B, Sivitz W, Baranetsky N, Cordle M, DeLuca H. Islet insulin release and net calcium retention in vitro in vitamin D–deficient rats. Diabetes. 1986;35(7):771-5.
Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler A-G. No effect of the 1α, 25-dihydroxyvitamin D3 on β-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes care. 2010;33(7):1443-8.
Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E. Clinical implications of vitamin D deficiency. Przeglad menopauzalny= Menopause review. 2015;14(2):75.
Adams JS, Hewison M. Update in vitamin D. The Journal of Clinical Endocrinology & Metabolism. 2010;95(2):471-8.
Thomas GN, ó Hartaigh B, Bosch JA, Pilz S, Loerbroks A, Kleber ME, et al. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes care. 2012;35(5):1158-64.
Bachali S, Dasu K, Ramalingam K, Naidu J. Vitamin d deficiency and insulin resistance in normal and type 2 diabetes subjects. Indian Journal of Clinical Biochemistry. 2013;28(1):74-8.
Parildar H, Cigerli O, Unal D, Gulmez O, Demirag NG. The impact of vitamin D replacement on glucose metabolism. Pakistan journal of medical sciences. 2013;29(6):1311.
Sipahi S, Acikgoz SB, Genc AB, Yildirim M, Solak Y, Tamer A. The association of vitamin D status and vitamin D replacement therapy with glycemic control, serum uric acid levels, and microalbuminuria in patients with type 2 diabetes and chronic kidney disease. Medical principles and practice. 2017;26(2):146-51.
Martini LA, Catania AS, Ferreira SR. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutrition reviews. 2010;68(6):341-54.
Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P. Vitamin D and glycemic control in diabetes mellitus type 2. Therapeutic advances in endocrinology and metabolism. 2013;4(4):122-8.
Calvo-Romero JM, Ramiro-Lozano JM. Metabolic effects of supplementation with vitamin D in type 2 diabetic patients with vitamin D deficiency. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016;10(2):72-4.
Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. 2018;10(3):375.
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). European heart journal. 2020;41(2):255-323.
Dunlop TW, Väisänen S, Frank C, Molnar F, Sinkkonen L, Carlberg C. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor. Journal of molecular biology. 2005;349(2):248-60.
Bonakdaran S, F Nejad A, Abdol-Reza V, Hatefi A, Shakeri M. Impact of oral 1, 25-dihydroxy vitamin D (calcitriol) replacement therapy on coronary artery risk factors in type 2 diabetic patients. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2013;13(4):295-300.
Maestro B, Molero S, Bajo S, Davila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1, 25‐dihydroxyvitamin D3. Cell Biochemistry and Function: Cellular biochemistry and its modulation by active agents or disease. 2002;20(3):227-32.
Maestro B, Dávila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. The Journal of steroid biochemistry and molecular biology. 2003;84(2-3):223-30.
Kadowaki S, Norman AW. Pancreatic vitamin D-dependent calcium binding protein: biochemical properties and response to vitamin D. Archives of biochemistry and biophysics. 1984;233(1):228-36.
Fadda GZ, Akmal M, Lipson L, Massry S. Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. American Journal of Physiology-Endocrinology and Metabolism. 1990;258(6):E975-E84.
Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1, 25-Dihydroxyvitamin D3 works as anti-inflammatory. Diabetes research and clinical practice. 2007;77(1):47-57.
BAO W, SONG Y, BERTRAND KA, TOBIAS DK, OLSEN SF, CHAVARRO JE, et al. Pre-pregnancy habitual intake of vitamin D from diet and supplements in relation to risk of gestational diabetes mellitus: a prospective cohort study.
Tint MT, Chong MF, Aris IM, Godfrey KM, Quah PL, Kapur J, et al. Association between maternal mid-gestation vitamin D status and neonatal abdominal adiposity. International Journal of Obesity. 2018;42(7):1296-305.
McGill A-T, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D 3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutrition journal. 2008;7(1):1-5.
Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes care. 2009;32(7):1278-83.
Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1C levels with vitamin D status in US adults: data from the National Health and Nutrition Examination Survey. Diabetes Care. 2010;33(6):1236-8.
De Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes care. 2008;31(4):701-7.
Toxqui L, Blanco-Rojo R, Wright I, Pérez-Granados AM, Vaquero MP. Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial. Nutrients. 2013;5(12):4966-77.
Scragg R, Slow S, Stewart AW, Jennings LC, Chambers ST, Priest PC, et al. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension. 2014;64(4):725-30.
Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension. 2015;65(6):1195-201.
Yang Yy, Liu Jm. What can we learn from the Vitamin D and Type 2 Diabetes (D2d) Study? Journal of diabetes. 2020;12(3):259-61.
- Abstract Viewed: 252 times
- pdf Downloaded: 164 times